These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20976576)

  • 41. Nephrogenic systemic fibrosis and gadolinium-enhanced magnetic resonance imaging: does a US Food and Drug Administration alert influence practice patterns in CKD?
    Martin DR
    Am J Kidney Dis; 2010 Sep; 56(3):427-30. PubMed ID: 20728788
    [No Abstract]   [Full Text] [Related]  

  • 42. ACOG Committee Opinion No. 387 November 2007: pharmaceutical compounding.
    American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2007 Nov; 110(5):1213-4. PubMed ID: 17978147
    [No Abstract]   [Full Text] [Related]  

  • 43. Economic evaluation of sublingual immunotherapy: an analysis of literature.
    Ciprandi G; Agostinis F; Amoroso S; Ariano R; Barbato A; Bassi M; Cadario G; Campi P; Cardinale F; Romano C; Incorvaia C; Danneo R; Dal Bo S; Di Gioacchino M; Fiocchi A; Galimberti M; Galli E; Giovannini M; La Grutta S; Lombardi C; Marcucci F; Marseglia GL; Mastrandrea F; Minelli M; Nettis E; Novembre E; Ortolani C; Pajno G; Piras PP; Passalacqua G; Patriarca G; Pucci S; Quercia O; Romano A; Schiavino D; Sforza M; Tosca MA; Tripodi S; Zambito M; Puccinelli P; Frati F
    Eur Ann Allergy Clin Immunol; 2007; 39 Spec No():21-6. PubMed ID: 18924463
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The "art" of medicine and the "smokescreen" of the randomized trial off-label use of vascular devices.
    Ansel GM; Jaff MR
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):998-1002. PubMed ID: 19021289
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Positive outcomes through the appropriate use of off-label prescribing.
    Bright JL
    Arch Intern Med; 2006 Dec 11-25; 166(22):2554-5; author reply 2555. PubMed ID: 17159026
    [No Abstract]   [Full Text] [Related]  

  • 46. ['Drops for allergy' in children: often applied, but not effective].
    Brand PL
    Ned Tijdschr Geneeskd; 2008 Feb; 152(5):241-2. PubMed ID: 18333536
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Future developments in sublingual immunotherapy.
    Didier A
    Allergy; 2006; 61 Suppl 81():29-31. PubMed ID: 16792604
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thinking outside the (black) box: a new research agenda.
    Seligman PJ
    Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):387-9. PubMed ID: 16739245
    [No Abstract]   [Full Text] [Related]  

  • 49. Sublingual immunotherapy: the optimism and the issues.
    Pajno GB
    J Allergy Clin Immunol; 2007 Apr; 119(4):796-801. PubMed ID: 17306355
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of sublingual immunotherapy not established.
    Ochando E
    Ann Allergy Asthma Immunol; 1995 Mar; 74(3):276-7. PubMed ID: 7889387
    [No Abstract]   [Full Text] [Related]  

  • 51. The future of sublingual immunotherapy.
    Marcucci F; Duse M; Frati F; Incorvaia C; Marseglia GL; La Rosa M
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):31-3. PubMed ID: 19944008
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unlicensed and off-label drug use in children.
    Bavdekar SB; Gogtay NJ
    J Postgrad Med; 2005; 51(4):249-52. PubMed ID: 16388164
    [No Abstract]   [Full Text] [Related]  

  • 53. The Vioxx debacle revisited.
    Good CB; Kelley CL
    Am J Med; 2005 Sep; 118(9):1055-6; author reply 1056-7. PubMed ID: 16164902
    [No Abstract]   [Full Text] [Related]  

  • 54. Drug shortages in America: what about the gastroenterologist?
    Menees SB; Vargo JJ; Bonta C; Mayo L; Jacobson BC
    Gastrointest Endosc; 2013 Apr; 77(4):641-5. PubMed ID: 23498144
    [No Abstract]   [Full Text] [Related]  

  • 55. Allergens.
    Esch RE
    Clin Rev Allergy Immunol; 2001 Oct; 21(2-3):89-91. PubMed ID: 11725609
    [No Abstract]   [Full Text] [Related]  

  • 56. Annual drug update: 2011 in review.
    Belavic JM
    Nurse Pract; 2012 Feb; 37(2):14-23; quiz 23-4. PubMed ID: 22215434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The US Military Considers Whether Controversial Opioid Is Fit for Battlefield Duty.
    Voelker R
    JAMA; 2019 Jun; 321(24):2389-2391. PubMed ID: 31166592
    [No Abstract]   [Full Text] [Related]  

  • 58. Legal status and regulation of allergenic products in the United States.
    Menzies S; Huynh S; Rabin RL
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2013; 97():9-14. PubMed ID: 24912306
    [No Abstract]   [Full Text] [Related]  

  • 59. TB test approved.
    AIDS Patient Care STDS; 2002 Jan; 16(1):53. PubMed ID: 11839220
    [No Abstract]   [Full Text] [Related]  

  • 60. [Allergen-specific immunotherapy: current concepts and future directions].
    Cheng L; Chen RX
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Dec; 46(12):972-5. PubMed ID: 22336006
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.